ANI PHARMACEUTICALS, INC Interest Expense
ANI PHARMACEUTICALS, INC (ANIP) reported Interest Expense of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2014-05-12
- ANI PHARMACEUTICALS, INC interest expense for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC interest expense for the quarter ending 2013-12-31 was $98.00, a 99.89% decline year-over-year.
- ANI PHARMACEUTICALS, INC interest expense for the quarter ending 2013-09-30 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC interest expense for the quarter ending 2013-06-30 was $374.48K, a 25.25% decline year-over-year.
- ANI PHARMACEUTICALS, INC interest expense for fiscal 2013 was $467.00K, a 64.81% decline from fiscal 2012.
- ANI PHARMACEUTICALS, INC interest expense for fiscal 2012 was $1.33M, a 94.70% increase from fiscal 2011.
- ANI PHARMACEUTICALS, INC interest expense for fiscal 2011 was $681.57K, a 0.95% decline from fiscal 2010.
- ANI PHARMACEUTICALS, INC interest expense for fiscal 2010 was $688.08K.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $98.00 derived: sum of 2 quarters · filed 2014-05-12 | $98.00 derived: sum of 3 quarters · filed 2014-05-12 | $374.57K derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2013-12-31 | $98.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $98.00 derived: sum of 2 quarters · filed 2014-02-28 | $374.57K derived: sum of 3 quarters · filed 2014-02-28 | $467.00K 10-K · filed 2014-02-28 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-07 | $374.48K derived: sum of 2 quarters · filed 2013-11-07 | $466.90K 10-Q · filed 2013-11-07 | $555.34K derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2013-06-30 | $374.48K 10-Q · filed 2013-08-09 | $466.90K 10-Q · filed 2013-08-09 | $555.34K derived: sum of 3 quarters · filed 2014-05-12 | $636.56K derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2013-03-31 | $93.00K 10-Q · filed 2014-05-12 | $64.67K 10-Q · filed 2013-05-10 | $180.86K derived: sum of 2 quarters · filed 2014-05-12 | $262.09K derived: sum of 3 quarters · filed 2014-05-12 | $763.09K derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2012-12-31 | $87.86K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $169.09K derived: sum of 2 quarters · filed 2014-02-28 | $670.09K derived: sum of 3 quarters · filed 2014-02-28 | $1.33M 10-K · filed 2014-02-28 | $348.02K 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $81.22K 10-Q · filed 2013-11-07 | $67.11K 10-Q · filed 2012-11-08 | $582.23K derived: sum of 2 quarters · filed 2013-11-07 | $1.24M 10-Q · filed 2013-11-07 | $283.35K 10-Q · filed 2012-11-08 | $872.00K derived: sum of 4 quarters · filed 2013-11-07 | ||
| 2012-06-30 | $501.00K 10-Q · filed 2013-08-09 | $92.05K 10-Q · filed 2012-08-01 | $1.16M 10-Q · filed 2013-08-09 | $216.24K 10-Q · filed 2012-08-01 | $790.77K derived: sum of 3 quarters · filed 2013-08-09 | $962.77K derived: sum of 4 quarters · filed 2013-08-09 | ||
| 2012-03-31 | $124.20K 10-Q · filed 2013-05-10 | $289.77K derived: sum of 2 quarters · filed 2013-05-10 | $461.77K derived: sum of 3 quarters · filed 2013-05-10 | $633.77K derived: sum of 4 quarters · filed 2013-05-10 | ||||
| 2011-12-31 | $165.57K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $337.57K derived: sum of 2 quarters · filed 2013-02-28 | $509.57K derived: sum of 3 quarters · filed 2013-02-28 | $681.57K 10-K · filed 2013-02-28 | ||||
| 2011-09-30 | $172.00K 10-Q · filed 2012-11-08 | $344.00K derived: sum of 2 quarters · filed 2012-11-08 | $516.00K 10-Q · filed 2012-11-08 | $688.00K derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $172.00K 10-Q · filed 2012-08-01 | $344.00K 10-Q · filed 2012-08-01 | $516.00K derived: sum of 3 quarters · filed 2013-02-28 | $688.00K derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $172.00K 10-Q · filed 2012-05-08 | $344.00K derived: sum of 2 quarters · filed 2013-02-28 | $516.00K derived: sum of 3 quarters · filed 2013-02-28 | $688.08K derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $344.00K derived: sum of 2 quarters · filed 2013-02-28 | $516.08K derived: sum of 3 quarters · filed 2013-02-28 | $688.08K 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $172.00K 10-Q · filed 2011-11-09 | $344.08K derived: sum of 2 quarters · filed 2011-11-09 | $516.08K 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $172.08K 10-Q · filed 2011-08-05 | $344.08K 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $147.03K 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |